Charles G. Knutson

机构：Amgen (United States), Novartis (China), Novartis (United States), Beckman Coulter Foundation, Harvard Global Health Institute

发表论文 41 篇 · 总被引 3785 次 · h-index 18

代表论文

• The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity (2019 · Nature · 被引 2299)
• Engineered human blood–brain barrier microfluidic model for vascular permeability analyses (2022 · Nature Protocols · 被引 257)
• An on-chip model of protein paracellular and transcellular permeability in the microcirculation (2019 · Biomaterials · 被引 118)
• Chemical and cytokine features of innate immunity characterize serum and tissue profiles in inflammatory bowel disease (2013 · Proceedings of the National Academy of Sciences · 被引 113)
• Application of Transmural Flow Across In Vitro Microvasculature Enables Direct Sampling of Interstitial Therapeutic Molecule Distribution (2019 · Small · 被引 63)
• The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants (2022 · Nature Biotechnology · 被引 60)